Brokerages Set Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Target Price at $11.54

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has been given a consensus recommendation of “Reduce” by the fourteen research firms that are covering the firm, MarketBeat.com reports. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $11.54.

WBA has been the topic of several recent analyst reports. Wolfe Research raised shares of Walgreens Boots Alliance to a “hold” rating in a research note on Monday, February 24th. Truist Financial dropped their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Bank of America raised their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Royal Bank of Canada raised their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and dropped their target price for the stock from $11.00 to $9.00 in a report on Friday, February 28th.

Walgreens Boots Alliance Stock Down 0.3 %

Shares of NASDAQ WBA opened at $11.23 on Wednesday. The firm has a market capitalization of $9.70 billion, a PE ratio of -1.10, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance has a 1 year low of $8.08 and a 1 year high of $22.05. The firm’s 50-day moving average is $10.83 and its 200-day moving average is $9.76.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same quarter last year, the firm earned $0.66 EPS. The company’s revenue for the quarter was up 7.6% on a year-over-year basis. Equities analysts expect that Walgreens Boots Alliance will post 1.6 EPS for the current year.

Hedge Funds Weigh In On Walgreens Boots Alliance

A number of institutional investors have recently added to or reduced their stakes in the company. Brooklyn Investment Group increased its holdings in Walgreens Boots Alliance by 21.1% during the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after buying an additional 830 shares during the last quarter. First Financial Corp IN boosted its position in Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares during the period. CWA Asset Management Group LLC boosted its position in Walgreens Boots Alliance by 9.2% during the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock worth $120,000 after purchasing an additional 1,084 shares during the period. Metis Global Partners LLC boosted its position in Walgreens Boots Alliance by 4.9% during the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator’s stock worth $222,000 after purchasing an additional 1,118 shares during the period. Finally, Harbour Investments Inc. boosted its position in shares of Walgreens Boots Alliance by 4.3% in the fourth quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator’s stock valued at $265,000 after acquiring an additional 1,165 shares during the period. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.